Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced synthesis of 5 alpha-pregnane-3 beta, 17 alpha-dihydroxyl-20-ketone via novel non-hydrogen debromination. Reliable supplier for Ganaxolone quality control intermediates.
Novel dynamic kinetic resolution method for R-2-naphthylethylamine. High yield, 99% ee. Cost-effective nickel catalyst. Reliable supply chain partner.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN111116501B details a novel catalytic method for synthesizing Lesinurad intermediates, eliminating chlorinated impurities and ensuring scalable API production.
Patent CN116554014B reveals high-purity fenofibrate preparation with improved impurity control and scalable commercial manufacturing capabilities for global supply chains.
Patent CN106892859B reveals a novel benzo[c,d]indole-polyamine conjugate with superior lysosome targeting and anti-metastasis activity for pharmaceutical manufacturing.
Novel 6-step synthesis from epoxy-pregnane. High yield, industrial scale. Cost-effective veterinary hormone intermediate manufacturing.
Novel 4-step synthesis route for Abiraterone acetate improves yield to 51.4% with mild conditions, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116082111B reveals chromium catalysis for 1,1,2-triarylethane. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel eight-step synthesis from L-asparagine avoids chiral resolution, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103626822B details a high-yield, mercury-free synthesis of 25-hydroxycholesterol, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106478623B reveals high-yield triazole isoquinoline synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel patent CN104725322B details efficient 2-aminopyrimidine synthesis. Offers high yield and cost advantages for supply chain stability and commercial scalability in drug manufacturing.
Patent CN106380452A reveals solvent reduction technology for oxfendazole. Enhances supply chain reliability and cost reduction in veterinary drugs manufacturing.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Patent CN119707868A details a novel synthesis for Viloxazine Impurity C enabling high-purity quality control and streamlined supply chain management for global pharmaceutical manufacturers.
Patent CN107176948B details a safer pimobendan route eliminating toxic reagents. This offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN110483460A reveals a room-temperature PIFA oxidation method for 3-selenocoumarin. Discover cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Patent CN111925312A reveals a novel one-pot synthesis for indolyl-substituted indole-3-ketones using PPh3. This method offers significant cost reduction in API manufacturing and high purity.